Sagimet Biosciences Inc
NASDAQ:SGMT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sagimet Biosciences Inc
NASDAQ:SGMT
|
US |
|
Siloam International Hospitals Tbk PT
F:2LS
|
ID |
|
A
|
Anheuser Busch Inbev SA
XBER:1NBA
|
BE |
|
B
|
BML Inc
XMUN:BMZ
|
JP |
|
D
|
Dexcom Inc
XBER:DC4
|
US |
|
N
|
Novozymes A/S
XMUN:NZM2
|
DK |
Wall St Price Targets
SGMT Price Targets Summary
Sagimet Biosciences Inc
According to Wall Street analysts, the average 1-year price target for
SGMT is 26.89 USD with a low forecast of 8.08 USD and a high forecast of 51.45 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SGMT's stock price target?
Price Target
26.89
USD
According to Wall Street analysts, the average 1-year price target for
SGMT is 26.89 USD with a low forecast of 8.08 USD and a high forecast of 51.45 USD.